Takeda
Takeda invests $125m in Maverick T-cell platform partnership
January 12, 2017Research and Development Maverick, Takeda
Takeda has announced its intention to invest $125 million in a partnership with Maverick Therapeutics to develop the latter’s T-cell …
Takeda to acquire Ariad in $5.2 billion deal
January 9, 2017Manufacturing and Production, Sales and Marketing Ariad, Takeda
Takeda has acquired US drug maker, Ariad Pharmaceuticals, in a deal worth $5.2 billion. Takeda has been looking to bolster …
Takeda to invest €40m in Dublin operations expansion
December 5, 2016Manufacturing and Production Dublin, Ireland, Nanlarotm, Takeda
Takeda has announced it is to invest $40 million in a new facility in Dublin, adding a new facility and …
Takeda to build €100 million dengue vaccine manufacturing plant
December 1, 2016Manufacturing and Production, Medical Communications Takeda, dengue, phase 3
Takeda have announced plans to spend more than €100 million in the construction of a new manufacturing plant in Singen, …
Takeda gains marketing authorisation for multiple myeloma pill
November 28, 2016Sales and Marketing Takeda, multiple myeloma
Takeda Pharmaceutical has announced that they have received conditional marketing authorisation for Ninlaro (ixazomib) for treatment of adult patients with …
Takeda appoint Marc Weeks to Digital Lead role
October 31, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, digital
Takeda UK have appointed Marc Weeks to the newly created role of digital lead. The creation of the role comes as …
Takeda enters $790m cancer development deal
October 11, 2016Manufacturing and Production, Research and Development Cancer, Crescendo Biologics, Takeda, clinical partnership, humabody
Takeda and Crescendo Biologics have shaken hands on a $790 million deal to develop and commercialise cancer therapeutics using Crescendo’s …
Takeda partners with Zydus to develop chikungunya vaccine
September 20, 2016Manufacturing and Production, Research and Development Takeda, Zydus Cadila, chikungunya
Zydus Cadila has teamed up with Takeda to develop a vaccine for the chikungunya virus. Zydus Cadila’s group firm Cadila …
Top Ten articles in the Pharma Industry this week
September 16, 2016Medical Communications Bayer, GSK, Gilead, GlaxoSmithKline, J&J, JJ, Pfizer, Roche, Sanofi, Takeda, aspen, google, monsanto
As we come to the end of another week, we’re looking back at an exciting week in the industry; there …
Takeda reportedly sets $15bn on US acquisitions
September 14, 2016Manufacturing and Production, Research and Development Takeda, acquisitions
Takeda Pharmaceuticals is reportedly willing to spend as much as $15 billion on acquisitions in the US in efforts to …
Takeda forms “first of its kind” developmental partnership with CRO
September 13, 2016Manufacturing and Production, Research and Development PRA Health Services, Takeda, partnership
Takeda and PRA Health Services have announced a new partnership that will see the Japanese pharma giant transfer 300 staffers …
Takeda begins Phase III dengue vaccine trial
September 8, 2016Research and Development Takeda, Vaccine, dengue, dengue vaccine, phase III, trial
Takeda Pharmaceuticals has announced the initiation of a global Phase III clinical trial to test its live-attenuated tetravalent dengue vaccine …
Takeda secures $312 million zika vaccine development contract
September 5, 2016Manufacturing and Production, Research and Development, Sales and Marketing Takeda, US government, Zika, world health organization
Takeda has announced that it has been granted a $312 million contract from the US government to develop an inactivated, …
Jobs to go at Takeda as it shuts down Cambridge facility
August 26, 2016Manufacturing and Production, Medical Communications Cambridge, Jobs, Takeda, closure
Takeda has announced plans to close its facility in Cambridge in the UK, to refocus its research and development operations …
Old CDF drug not recommended in initial NICE guidance due to lack of evidence
August 10, 2016Research and Development, Sales and Marketing Adcetris, Cancer Drugs Fund, NICE, Takeda, hodgkin's lymphoma
The National Institute for Health and Care Excellence (NICE) has published draft guidance not recommending Takeda’s Adectris (brentuximab vedotin), despite …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
